Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ANA Therapeutics initiates trial of oral niclosamide for Covid-19 treatment

pharmaceutical-technologyOctober 28, 2020

Tag: ANA Therapeutics , Niclosamide , COVID-19

PharmaSources Customer Service